A 10-year review of mBC

The Global Status of Advanced/Metastatic Breast Cancer 20052015 Decade Report analyzed the metastatic breast cancer (mBC) landscape over the past decade to highlight gaps in patient care, access to resources and support, and treatment outcomes for women around the world. This report was developed by Pfizer Oncology, working collaboratively with the European School of Oncology (ESO) under the framework of the International Consensus Conference for Advanced Breast Cancer (ABC). 

A steering committee of global multidisciplinary mBC advisors—composed of physicians, leaders of patient support organizations, and patients—contributed to the development of this report. 

Decade Report cover
Select a document to view or download:

Update link here